Recruitment for this study has ended, so applications are closed. You can still read the trial details, or browse similar trials that are currently recruiting.
Sponsor:
Merz Therapeutics GmbH
Code:
NCT07018713
Conditions
Chronic Migraine
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Xeomin
Placebo
Brief summary:
Conditions
Chronic Migraine
Study ID
NCT07018713
Start date
Aug 21, 2025
Status verified date
Oct, 2026
Completion date
Sep, 2027
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
808 participants
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Xeomin Dose A
experimental: Xeomin Dose B
placebo comparator: Placebo
Interventions
Xeomin
Placebo
Primary outcome measure
Sponsor
Merz Therapeutics GmbH
Last update posted
Oct 14, 2026
Last verified
Oct, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Merz Therapeutics GmbH on 2026-10-14. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.